1,188 filings
Page 3 of 60
8-K
h26y34l9r7bxeo
2 Jun 20
Entry into a Material Definitive Agreement
7:35am
8-K
jmnwz4t1q 872xpc65v
8 May 20
VIVUS Q1 2020 Earnings Conference Call
4:45pm
8-K
8oa6 a4oq
6 May 20
VIVUS Reports First Quarter 2020 Financial Results
4:10pm
8-K
7picy2fvwf6v6es
1 May 20
VIVUS Announces Agreement with IEH Biopharma LLC Granting the Company a 30-Day Grace Period to Restructure its Corporate Debt
8:30am
CT ORDER
jvzxc37l
24 Apr 20
Confidential treatment order
2:36pm
SC 13G
gpd1dwz9w hvlj
13 Apr 20
VIVUS / ARMISTICE CAPITAL ownership change
4:35pm
SC 13G
7lcddp9einuz
10 Apr 20
VIVUS / INTRACOASTAL CAPITAL ownership change
4:27pm
8-K
bcmij0cdmvr3be
3 Apr 20
VIVUS Announces Closing of $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
3:05pm
8-K
0i49x
2 Apr 20
Entry into a Material Definitive Agreement
5:28pm
424B5
e2121y
2 Apr 20
Prospectus supplement for primary offering
2:01pm
8-K
q6uln oo6j56zvp48
1 Apr 20
VIVUS Announces $11.55 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:00pm
SC 13G
4yjg4j dttuv8n53b7c
1 Apr 20
VIVUS / SABBY MANAGEMENT ownership change
9:24am
8-K
hb2vgf0yewyo8bt dlv
31 Mar 20
Other Events
7:35am
CT ORDER
a53defx2jd96s5
12 Mar 20
Confidential treatment order
1:06pm
8-K
pjwwm6 as7zmor
6 Mar 20
VIVUS Q4 2019 Earnings Conference Call
4:05pm
8-K
wlu tqdd6iuh24mcm
6 Mar 20
Entry into a Material Definitive Agreement
12:00am
424B5
uza5qx
6 Mar 20
Prospectus supplement for primary offering
12:00am
8-K
m7vcvax7r59vnbbhj4
3 Mar 20
VIVUS Reports Fourth Quarter and Full Year 2019 Financial Results
4:10pm